In this feature in Labiotech, leading figures in the UK life sciences industry were asked for their thoughts on the UK's 10-year science strategy - aimed at saving more lives and establishing the UK as a global science superpower. The plan involves investing in the scientific workforce and forging stronger partnerships with industry and academia.
In the article our CEO Mark Kotter talks about the importance of government support in enabling the UK to become a leading science superpower. He emphasises the need for the government to assist innovative companies like bit.bio in accessing significant investments, as this is currently their biggest challenge. Without such support, promising companies may have to seek investment outside the UK or delay their innovation pipeline.
Read the full article.
